While most measurements were obtained within approximately two months of either HIV/AIDS or fungal infection diagnosis, the lack of a strictly standardized schedule means that CD4+ levels may still have varied due to treatment response or disease progression, potentially leading to a misclassification of patients’ immune statuses. This evidence concerns the gene CD4 and AIDS.